Radiomic Phenotypes for Improving Early Prediction of Survival in Stage III Non-Small Cell Lung Cancer Adenocarcinoma after Chemoradiation

José Marcio Luna, Andrew R. Barsky, Russell T. Shinohara, Leonid Roshkovan, Michelle Hershman, Alexandra D. Dreyfuss, Hannah Horng, Carolyn Lou, Peter B. Noël, Keith A. Cengel, Sharyn Katz, Eric S. Diffenderfer, Despina Kontos

Research output: Contribution to journalArticlepeer-review

5 Scopus citations


We evaluate radiomic phenotypes derived from CT scans as early predictors of overall survival (OS) after chemoradiation in stage III primary lung adenocarcinoma. We retrospectively analyzed 110 thoracic CT scans acquired between April 2012−October 2018. Patients received a me-dian radiation dose of 66.6 Gy at 1.8 Gy/fraction delivered with proton (55.5%) and photon (44.5%) beam treatment, as well as concurrent chemotherapy (89%) with carboplatin-based (55.5%) and cis-platin-based (36.4%) doublets. A total of 56 death events were recorded. Using manual tumor seg-mentations, 107 radiomic features were extracted. Feature harmonization using ComBat was performed to mitigate image heterogeneity due to the presence or lack of intravenous contrast material and variability in CT scanner vendors. A binary radiomic phenotype to predict OS was derived through the unsupervised hierarchical clustering of the first principal components explaining 85% of the variance of the radiomic features. C-scores and likelihood ratio tests (LRT) were used to com-pare the performance of a baseline Cox model based on ECOG status and age, with a model integrating the radiomic phenotype with such clinical predictors. The model integrating the radiomic phenotype (C-score = 0.69, 95%CI = (0.62, 0.77)) significantly improved (< 0.005) upon the baseline model (C-score = 0.65, CI = (0.57, 0.73)). Our results suggest that harmonized radiomic phenotypes can significantly improve OS prediction in stage III NSCLC after chemoradiation.

Original languageEnglish
Article number700
Issue number3
StatePublished - Feb 1 2022


  • ComBat
  • Computed tomography
  • Non-small cell lung cancer
  • Overall survival
  • Radiomics


Dive into the research topics of 'Radiomic Phenotypes for Improving Early Prediction of Survival in Stage III Non-Small Cell Lung Cancer Adenocarcinoma after Chemoradiation'. Together they form a unique fingerprint.

Cite this